Back

The effect of combined ezetimibe and statin therapy versus statin therapy alone on coronary plaque volume assessed by intravascular ultrasound: a systematic review and meta-analysis.

26 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Coronary artery disease epidemiology and outcomes Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Paul Min Thein

Monash Health, Melbourne (Australia)

14 More presentations in this session

Presentation thumbnail
Doctor S. Nakamura (Tokyo, JP)
Abstract
Presentation thumbnail
Professor K. Ray (London, GB)
Abstract
Presentation thumbnail
Mr J. Du (Beijing, CN)
Abstract
Presentation thumbnail
Doctor D. Terentes-Printzios (Athens, GR)
Abstract Slides
Presentation thumbnail
Professor V. Schettler (Goettingen, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Coronary artery disease epidemiology and outcomes

The Event

Event poster

ESC Congress 2018

26 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Comparing coronary artery plaque regression in patients treated with ezetimibe or PCSK9 inhibitors following acute coronary syndrome: a systematic review and meta-analysis
29 August 2025
thumbnail
Congress Presentation
The upfront lipid-lowering combination therapy of statins and ezetimibe vs statin monotherapy in the reduction of cardiovascular outcomes. A meta-analysis.
30 August 2024
thumbnail
Congress Presentation
Carotid plaques stabilization and regression with evolocumab
1 September 2025
thumbnail
Congress Presentation
Impact of bempedoic acid alone and combined with ezetimibe on ldl-cholesterol reduction: graphical evidence and retrospective analysis of a real-world clinical cohort
24 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources